6.95 USD
▼-0.29-4.01%
盘后 7.83 0.00%
2026-09-16
市值
$63.97M
市盈率
—
EPS
-10.88
股息率
—
52 周区间
3.58 – 14.21
成交量
46.42K
Beta
2.05
目标价
17.33
52W 低 3.5852W 高 14.21
价格走势
公司简介
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company’s lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clini...